Primary Device ID | 10190302012065 |
NIH Device Record Key | f1824d02-fc38-4a10-8766-1592f332f2a2 |
Commercial Distribution Status | In Commercial Distribution |
Brand Name | Human CXCR4 (CD184) R-PE Conjugate |
Version Model Number | MHCXCR404 |
Company DUNS | 080131636 |
Company Name | LIFE TECHNOLOGIES CORPORATION |
Device Count | 1 |
DM Exempt | true |
Pre-market Exempt | true |
MRI Safety Status | Labeling does not contain MRI Safety Information |
Human Cell/Tissue Product | false |
Device Kit | false |
Device Combination Product | false |
Single Use | false |
Lot Batch | true |
Serial Number | false |
Manufacturing Date | false |
Expiration Date | true |
Donation Id Number | false |
Contains Natural Rubber Latex | false |
Labeled No Natural Rubber Latex | false |
RX Perscription | true |
OTC Over-The-Counter | false |
Device Issuing Agency | Device ID |
---|---|
GS1 | 10190302012065 [Primary] |
MVU | Reagents, specific, analyte |
Steralize Prior To Use | false |
Device Is Sterile | false |
Public Version Status | Update |
Device Record Status | Published |
Public Version Number | 2 |
Public Version Date | 2024-06-04 |
Device Publish Date | 2018-06-15 |
10190302005197 - Aim -V™ Medium | 2024-06-04 AIM V MED |
10190302012041 - Human CD99 FITC Conjugate | 2024-06-04 HU CD99 3B2/TA8 FITC MAB |
10190302012058 - Human CD99 R-PE Conjugate | 2024-06-04 HU CD99 3B2/TA8 PE MAB |
10190302012065 - Human CXCR4 (CD184) R-PE Conjugate | 2024-06-04HU CXCR4 12G5 PE MAB |
10190302012065 - Human CXCR4 (CD184) R-PE Conjugate | 2024-06-04 HU CXCR4 12G5 PE MAB |
10190302012164 - Anti-Human HLA-DR (Class II) FITC Conjugate | 2024-06-04 HU HLA-DR TU36 FITC MAB |
10190302012171 - Anti-Human HLA-DR (Class II) R-PE Conjugate | 2024-06-04 HU HLA-DR TU36 PE MAB |
10190302012188 - Anti-Human HLA-DR (Class II) APC Conjugate | 2024-06-04 HU HLA-DR TU36 APC MAB |
10190302012195 - Anti-Human HLA-DR (Class II) PE-Texas Red® Conjugate | 2024-06-04 HU HLA-DR TU36 PE-TX RED MAB |